p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

• No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinoma

  2026 European Journal of Cancer article Medicine Endometrial and Cervical Cancer Treatments Open access

  0

  citations
• Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological Correlates

  2024 Modern Pathology article Medicine Endometrial and Cervical Cancer Treatments Open access

  3

  citations
• Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

  2024 The Lancet Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access

  24

  citations
• Prognostic value of molecular classification in stage IV endometrial cancer

  2024 International Journal of Gynecological Cancer article Medicine Endometrial and Cervical Cancer Treatments Open access

  12

  citations
• Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

  2023 Clinical Cancer Research article Medicine Endometrial and Cervical Cancer Treatments Open access

  39

  citations
• QPOLE : A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

  2023 JCO Global Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access

  28

  citations
• The Best of Both Worlds: Combining the Molecular and Traditional (Histotype/Grade) Endometrial Cancer Classification

  2022 AJSP Review and Reports article Medicine Endometrial and Cervical Cancer Treatments

  1

  citations
• The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep learning

  2022 Frontiers in Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access

  20

  citations
• p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

  2022 Modern Pathology article Medicine Endometrial and Cervical Cancer Treatments Open access

  175

  citations
• Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  2022 Annals of Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access

  657

  citations
• Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment

  2022 Gynecologic Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access

  109

  citations
• Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies

  2021 International Journal of Gynecological Pathology article Medicine Endometrial and Cervical Cancer Treatments

  17

  citations
• The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer

  2021 Therapeutic Advances in Medical Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access

  85

  citations
• Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes

  2020 Gynecologic Oncology article Medicine Genital Health and Disease Open access

  137

  citations
• Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

  2020 Journal of Clinical Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access cited by 1 patent

  877

  citations
• Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma

  2020 Clinical Cancer Research article Medicine Ovarian cancer diagnosis and treatment Open access

  69

  citations
• Progress in the management of endometrial cancer (subtypes, immunotherapy, alterations in PIK3CA pathway): data and perspectives

  2020 Current Opinion in Oncology article Medicine Endometrial and Cervical Cancer Treatments

  15

  citations
• Immunohistochemistry and Next Generation Sequencing are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies

  2020 medRxiv preprint Medicine Endometrial and Cervical Cancer Treatments Open access

  4

  citations
• Performance of the pattern‐based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma

  2020 Histopathology article Medicine Genital Health and Disease Open access

  75

  citations

19 results